Back to Search
BRUCE SANDS, M.D.
M.D.
Specialist
NPI: 1073611190Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study.
PMID 19637334·Inflamm Bowel Dis·2010
2-rct
What could the program have done differently? A qualitative examination of reasons for leaving outpatient treatment.
PMID 19339133·J Subst Abuse Treat·2009
8-other
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
PMID 19596014·Gastroenterology·2009
4-observational
Intracellular MUC1 peptides inhibit cancer progression.
PMID 19118037·Clin Cancer Res·2009
7-preclinical
Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists.
PMID 19172125·J Pediatr Gastroenterol Nutr·2009
8-other
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.
PMID 19558997·Clin Gastroenterol Hepatol·2009
1-meta
Validation of interactive voice response system administration of the Short Inflammatory Bowel Disease Questionnaire.
PMID 19023897·Inflamm Bowel Dis·2009
2-rct
Are adult patients more tolerant of treatment risks than parents of juvenile patients?
PMID 18826414·Risk Anal·2009
8-other
Epidemiology of inflammatory bowel disease and overview of pathogenesis.
PMID 19385381·Med Health R I·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1324 N SHERIDAN RD
WAUKEGAN, IL 60085 - Phone
- (847) 360-4023
Quick Facts
- NPI
- 1073611190
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile